Elauwit Connection, Inc.
ELWT Nasdaq Communications Services, Nec Financials FY2024βFY2025
What Elauwit Connection, Inc. does
No business description yet.
- Legal name
- Elauwit Connection, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001104659-26-037748
0002063863
Revenue and margins
Elauwit Connection, Inc. had $21.6M of revenue in fiscal 2025, up 154.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Elauwit Connection, Inc. returned $2.0M to shareholders in fiscal 2025. The diluted share count rose 48.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Elauwit Connection, Inc. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $0.3M | $6.2M |
| Debt incl. finance leases | $3.4M | $2.0M |
| Debt / equity | β | 0.5x |
| Current ratio | 0.7x | 1.7x |
| Quick ratio | 0.6x | 1.5x |
| Total assets | $7.7M | $11.9M |
| Total liabilities | $12.3M | $7.5M |
| Shareholders' equity | β$4.5M | $4.4M |
| Net debt (β = net cash) | $3.1M | β$4.2M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | β | β |
| Cash from operations is positive | β | β |
| Return on assets rose | β | β |
| Cash from operations exceeds net income | β | β |
| Debt fell relative to assets | β | β |
| Current ratio rose | β | β |
| Share count didn't rise | β | β |
| Gross margin rose | β | β |
| Revenue rose relative to assets | β | β |
| F-score | β / 3 | 5 / 9 |
| Accruals ratio | 5.1% | 15.1% |
| Altman Z'' | β9.69 | β3.20 |
2 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $8.5M | $21.6M |
| Gross profit | $1.2M | $4.0M |
| Research and development | $0.0M | $0.0M |
| Operating income | β$3.2M | β$3.7M |
| Pretax income | β$3.5M | β$4.2M |
| Income tax | $0.0M | β |
| Net income | β$3.5M | β$4.2M |
| Diluted EPS | β$0.98 | β$0.80 |
| Diluted shares | 0.00B | 0.01B |
| Cash flow | ||
| Cash from operations | β$3.9M | β$5.7M |
| Stock-based compensation | β | $0.0M |
| Share buybacks | β | $2.0M |
| Dividends and buybacks | β | $2.0M |
| Balance sheet | ||
| Cash and short-term investments | $0.3M | $6.2M |
| Total debt | $3.4M | $2.0M |
| Current assets | $6.7M | $10.3M |
| Current liabilities | $9.2M | $6.2M |
| Inventory | $1.6M | $1.0M |
| Total assets | $7.7M | $11.9M |
| Total liabilities | $12.3M | $7.5M |
| Shareholders' equity | β$4.5M | $4.4M |
| Margins | ||
| Gross margin | 13.7% | 18.5% |
| Operating margin | β37.9% | β17.1% |
| Net margin | β40.9% | β19.6% |
| Returns | ||
| Return on capital | β | β1,134.8% |
| Return on capital employed | 221.9% | β64.8% |
| Return on assets | β45.0% | β43.0% |
| Return on tangible equity | β | β95.7% |
| Growth | ||
| Revenue growth | β | 154.5% |
| Share count change | β | 48.3% |
| Financial health | ||
| Debt / equity | β | 0.5x |
| Current ratio | 0.7x | 1.7x |
| Quick ratio | 0.6x | 1.5x |
| Capital allocation | ||
| Stock comp / revenue | β | 0.0% |
| Quality scores | ||
| Piotroski F-score | β | 5.0 |
| Altman Z'' | β9.7 | β3.2 |
| Accruals ratio | 5.1% | 15.1% |
Source: SEC EDGAR XBRL filings (CIK 0002063863). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.